{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:30:43Z","timestamp":1787027443844,"version":"build-2736575974"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Apolipoprotein-A1 (Apo-A1) acts as a negative acute phase protein (APP) during inflammatory states, and has a potential prognostic value in people and dogs with sepsis. The aim of this retrospective study was to investigate the association of serum Apo-A1 concentration with disease severity, multiorgan dysfunction syndrome (MODS) and outcome in a population of dogs with sepsis, and to assess its correlation with major canine APPs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Ninety-nine dogs with uncomplicated sepsis (\n                      <jats:italic>n<\/jats:italic>\n                      = 78) or septic shock (\n                      <jats:italic>n<\/jats:italic>\n                      = 21) were included. The serum concentration of Apo-A1, C-reactive protein (CRP) and serum amyloid A (SAA) were recorded, alongside the canine acute patient physiologic and laboratory evaluation fast (APPLE\n                      <jats:sub>fast<\/jats:sub>\n                      ) score and the presence of MODS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Dogs with septic shock had significantly lower serum Apo-A1 concentrations (106.3 \u00b1 22.7 mg\/dl; reference interval: 123.0\u2013142.3 mg\/dl), higher APPLE\n                      <jats:sub>fast<\/jats:sub>\n                      score (30, 13\u201338) and greater frequency of MODS (67%) compared to those with uncomplicated sepsis (117.9 \u00b1 19.3 mg\/dl; 25, 6\u201333 and 8%, respectively) (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0201;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0005; P &amp;lt; 0.0001, respectively). Similarly, dogs with MODS had significantly lower serum Apo-A1 concentrations (104.1 \u00b1 4.6 mg\/dl) and higher APPLE\n                      <jats:sub>fast<\/jats:sub>\n                      score values (31, 13\u201338) compared to those without MODS (118.32 \u00b1 2.1 mg\/dl and 26, 6\u201333, respectively) (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0050 and\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0038, respectively). Conversely, neither CRP nor SAA were different between these groups. No difference in serum APPs concentrations was detected between survivors and non-survivors. Significant negative correlations were detected between serum Apo-A1 and SAA (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0056,\n                      <jats:italic>r<\/jats:italic>\n                      = \u22120.277), and between serum Apo-A1 and the APPLE\n                      <jats:sub>fast<\/jats:sub>\n                      score (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0027,\n                      <jats:italic>r<\/jats:italic>\n                      = \u22120.3). In this population, higher values of the APPLE\n                      <jats:sub>fast<\/jats:sub>\n                      score and the presence of MODS were independently associated with a higher risk of death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Our study shows that Apo-A1 is a useful biomarker of sepsis severity in dogs, since it is decreased in those with septic shock and MODS. Further prospective investigations are deemed to evaluate the applicability of Apo-A1 to predict sepsis course and response to treatment in septic dogs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fvets.2023.1098322","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T01:41:44Z","timestamp":1677721304000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Apolipoprotein A1 and serum amyloid A in dogs with sepsis and septic shock"],"prefix":"10.3389","volume":"10","author":[{"given":"Cecilia","family":"Bulgarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ciuffoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Troia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Goggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Giunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-02860-3","article-title":"High-density lipoproteins during sepsis: from bench to bedside","volume":"24","author":"Tanaka","year":"2020","journal-title":"Critical Care."},{"key":"B2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/978-3-319-09665-0_15","article-title":"HDL in infectious diseases and sepsis","volume-title":"High Density Lipoproteins Handbook of Experimental Pharmacology.","author":"Pirillo","year":"2015"},{"key":"B3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/cvr\/cvu150","article-title":"HDL in innate and adaptive immunity","volume":"103","author":"Catapano","year":"2014","journal-title":"Cardiovasc Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1097\/01.CCM.0000171183.79525.6B","article-title":"Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis","volume":"33","author":"Chien","year":"2005","journal-title":"Crit Care Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.nut.2017.09.015","article-title":"Changes in lipid metabolism in pediatric patients with severe sepsis and septic shock","volume":"47","author":"Bermudes","year":"2018","journal-title":"Nutrition."},{"key":"B6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.cimid.2016.10.002","article-title":"Serum apolipoprotein-A1 as a possible biomarker for monitoring treatment of canine leishmaniosis","volume":"49","author":"Escribano","year":"2016","journal-title":"Comp Immunol Microbiol Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/vec.12257","article-title":"Prospective evaluation of the acute patient physiologic and laboratory evaluation score and an extended clinicopathological profile in dogs with systemic inflammatory esponse syndrome","volume":"25","author":"Giunti","year":"2015","journal-title":"J Vet Emerg Crit Care."},{"key":"B8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s15010-017-1022-3","article-title":"Lipid testing in infectious diseases: possible role in diagnosis and prognosis","volume":"45","author":"Filippas-Ntekouan","year":"2017","journal-title":"Infection."},{"key":"B9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.intimp.2018.07.024","article-title":"Prognostic value of the biomarkers serum amyloid A and nitric oxide in patients with sepsis","volume":"62","author":"Yu","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/jvim.14631","article-title":"The utility of acute-phase proteins in the assessment of treatment response in dogs with bacterial pneumonia","volume":"31","author":"Viitanen","year":"2017","journal-title":"J Vet Intern Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1939-165X.2005.tb00019.x","article-title":"Acute phase proteins in dogs and cats: current knowledge and future perspectives","volume":"34","author":"Ceron","year":"2005","journal-title":"Vet Clin Pathol."},{"key":"B12","first-page":"161","article-title":"Comparison of serum amyloid A and C-reactive protein as diagnostic markers of systemic inflammation in dogs","volume":"55","author":"Christensen","year":"2014","journal-title":"Can Vet J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-014-0273-9","article-title":"Increased concentrations of serum amyloid A in dogs with sepsis caused by pyometra","volume":"10","author":"Jitpean","year":"2014","journal-title":"BMC Vet Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.theriogenology.2014.02.014","article-title":"Serum insulin-like growth factor-I, iron, C-reactive protein, and serum amyloid A for prediction of outcome in dogs with pyometra","volume":"82","author":"Jitpean","year":"2014","journal-title":"Theriogenology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fvets.2020.00263","article-title":"Evaluation of serum apolipoprotein A1 in canine sepsis","volume":"7","author":"Giunti","year":"2020","journal-title":"Fron Vet Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5935\/0103-507X.20130047","article-title":"Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock","volume":"24","author":"Ranzani","year":"2013","journal-title":"Rev Bras Ter Insensiva."},{"key":"B17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6692528","DOI":"10.3389\/fvets.2021.692528","article-title":"Classification of septic shock phenotypes based on the presence of hypotension and hyperlactatemia in cats","volume":"8","author":"Troia","year":"2021","journal-title":"Fron Vet Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/j.1939-1676.2010.0552.x","article-title":"The acute patient physiologic and laboratory evaluation (APPLE) score: a severity of illness stratification system for hospitalized dogs","volume":"24","author":"Hayes","year":"2010","journal-title":"J Vet Intern Med."},{"key":"B20","first-page":"318","article-title":"Validation of a human immunoturbidimetric assay for measuring canine C-reactive protein","volume":"34","author":"Gentilini","year":"2005","journal-title":"Vet Clin Path."},{"key":"B21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.tvjl.2012.05.007","article-title":"Evaluation of an automated assay based on monoclonal anti-human serum amyloid A (SAA) antibodies for measurement of canine, feline, and equine SAA","volume":"194","author":"Christensen","year":"2012","journal-title":"Vet J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4172\/2155-9929.1000182","article-title":"Long term stability of parameters of lipid metabolism in frozen human serum: triglycerides, free fatty acids, total-, HDL- and LDL-cholesterol, apolipoprotein-A1 and B","volume":"5","author":"Jansen","year":"2014","journal-title":"J Mol Biomark Diagn."},{"key":"B23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.clinbiochem.2014.12.006","article-title":"Stability of selected serum hormones and lipids after long-term storage in the Janus Serum bank","volume":"48","author":"Gislefoss","year":"2015","journal-title":"Clin Biochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-018-1427-y","article-title":"Plasma procalcitonin concentrations predict organ dysfunction and outcome in dogs with sepsis","volume":"14","author":"Tro\u00eca","year":"2018","journal-title":"BMC Vet Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.nut.2018.04.007","article-title":"Lipid profile associated with the systemic inflammatory response syndrome and sepsis in critically ill patients","volume":"55","author":"Golucci","year":"2018","journal-title":"Nutrition."},{"key":"B26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/INF.0000000000002682","article-title":"Clinical value of serum amyloid-A protein, high-density lipoprotein cholesterol and apolipoprotein-A1 in the diagnosis and follow-up neonatal sepsis","volume":"39","author":"Bourika","year":"2020","journal-title":"Pediatr Infect Dis J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/jvim.15537","article-title":"Association of acute Babesia canis infection and serum lipid, lipoprotein, and apoprotein concentrations in dogs","volume":"33","author":"Milanovi\u0107","year":"2019","journal-title":"J Vet Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/jvim.12474","article-title":"Serum cardiac troponin I concentrations in dogs with systemic inflammatory response syndrome","volume":"29","author":"Hamacher","year":"2015","journal-title":"J Vet Intern Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21037\/jeccm.2017.09.04","article-title":"Sepsis-induced multi-organ dysfunction syndrome-a mechanistic approach","volume":"1","author":"Spapen","year":"2017","journal-title":"J Emerg Crit Care Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2460\/javma.236.1.83","article-title":"Association between outcome and organ system dysfunction in dogs with sepsis: 114 cases (2003\u20132007)","volume":"236","author":"Kenney","year":"2010","journal-title":"J Am Vet Med Assoc"},{"key":"B31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/vec.12868","article-title":"Utility of admission lactate concentration, lactate variables, and shock index in outcome assessment in dogs diagnosed with shock","volume":"29","author":"Zollo","year":"2019","journal-title":"J Vet Emerg Crit Care."},{"key":"B32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/vec.13106","article-title":"Retrospective evaluation of the prognostic utility of plasma lactate concentration and serial lactate measurements in dogs and cats presented to the emergency room (January 2012\u2013December 2016): 4863 cases","volume":"32","author":"Saint-Pierre","year":"2022","journal-title":"J Vet Emerg Crit Care."},{"key":"B33","doi-asserted-by":"publisher","first-page":"789298","DOI":"10.1155\/2015\/789298","article-title":"Prognostic implications of serum lipid metabolism over time during sepsis","volume":"2015","author":"Lee","year":"2015","journal-title":"Biomed Res Int"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2023.1098322\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T01:41:48Z","timestamp":1677721308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2023.1098322\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":33,"alternative-id":["10.3389\/fvets.2023.1098322"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2023.1098322","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"article-number":"1098322"}}